X Jornada Mineira de Reumatologia
1º Dia - 11/23/18
2º Dia - 11/24/18

Marcadores de alvos terapêuticos das doenças autoimunes Voltar

Rodrigo Luppino Assad

Mesa 3 - Atualização Terapêutica - Antônio Scafuto Scotton

Artigo Autor(es) Referência
Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets. Long Hai, Wang Xin, Chen Yongjian, Wang Ling, Zhao Ming, Lu Qianjin Cancer letters. 2018 08; 428(08):90-103. doi: 10.1016/j.canlet.2018.04.016. pii: S0304-3835(18)30277-5.
Emerging role of semaphorin-3A in autoimmune diseases. Liu Li-Na, Li Xiao-Mei, Ye Dong-Qing, Pan Hai-Feng Inflammopharmacology. 2018 Jun; 26(Jun):655-665. doi: 10.1007/s10787-018-0484-y. pii: .
Ficolin-1 is a promising therapeutic target for autoimmune diseases. Katayama Michihito, Ota Kaori, Nagi-Miura Noriko, Ohno Naohito, Yabuta Norikazu, Nojima Hiroshi, Kumanogoh Atsushi, Hirano Toru International immunology. 2019 02; 31(02):23-32. doi: 10.1093/intimm/dxy056. pii: .
NLRP3: A promising therapeutic target for autoimmune diseases. Shen Hui-Hui, Yang Yue-Xin, Meng Xiang, Luo Xiao-Yun, Li Xiao-Mei, Shuai Zong-Wen, Ye Dong-Qing, Pan Hai-Feng Autoimmunity reviews. 2018 Jul; 17(Jul):694-702. doi: 10.1016/j.autrev.2018.01.020. pii: S1568-9972(18)30109-5.
Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. Chandy K George, Norton Raymond S Current opinion in chemical biology. 2017 Jun; 38(Jun):97-107. doi: 10.1016/j.cbpa.2017.02.015. pii: S1367-5931(16)30205-8.
The MicroRNA-326: Autoimmune diseases, diagnostic biomarker, and therapeutic target. Jadideslam Golamreza, Ansarin Khalil, Sakhinia Ebrahim, Alipour Shahriar, Pouremamali Farhad, Khabbazi Alireza Journal of cellular physiology. 2018 12; 233(12):9209-9222. doi: 10.1002/jcp.26949. pii: .
The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases. Dragovich Matthew A, Mor Adam Autoimmunity reviews. 2018 Jul; 17(Jul):674-682. doi: 10.1016/j.autrev.2018.01.018. pii: S1568-9972(18)30107-1.
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. Mao-Draayer Yang, Sarazin Jeffrey, Fox David, Schiopu Elena Clinical immunology (Orlando, Fla.). 2017 02; 175(02):10-15. doi: 10.1016/j.clim.2016.11.008. pii: S1521-6616(16)30313-8.
Nenhuma revista foi definida para este congresso.